View Medicus Pharma Ltd MDCX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Medicus Pharma (NASDAQ:MDCX) reported first quarter 2026 financial results on Thursday, highlighting progress across its SkinJect and Teverelix clinical programs while continuing efforts to strengthen ...
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Medicus Pharma Ltd. (NASDAQ:MDCX) is ...
This small-ticket transaction matters far more than its size suggests. The post Pro Medicus just struck a revolutionary AI ...
In April, Medicus Pharma Ltd. (NASDAQ:MDCX) agreed to acquire all of Antev’s issued and outstanding shares on a share exchange. Antev is a clinical-stage biotech company developing Teverelix, a ...
SkinJect® , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...
The Pro Medicus share price is rallying again as investors respond to the company’s latest move in healthcare AI.
12d
Health Check: For Pro Medicus, lightning strikes twice on another ASX-listed imaging up and comer
Pro Medicus strikes $10-20 million investment deal with heart imager Echo IQ, sending the latter’s shares up 50% • The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results